Filtered By:
Management: Funding
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 373 results found since Jan 2013.
Anthony Fauci, loved and hated, plots his next move: ‘I’m not going to sit in my house’
In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in U.S. history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.
“What am I going to do with this plant? It’s a monster. I can’t fit it in any other plac...
Source: ScienceNOW - September 1, 2022 Category: Science Source Type: news
News at a glance: New gene therapy, Europe ’s drought, and a black hole’s photon ring
ARCHAEOLOGY
Drought exposes ‘Spanish Stonehenge’ for study
Scientists are rushing to examine a 7000-year-old stone circle in central Spain that had been drowned by a reservoir for decades and was uncovered after the drought plaguing Europe lowered water levels. Nicknamed the “Spanish Stonehenge”—although 2000 years older than the U.K. stone circle—the Dolmen of Guadalperal (above) was described by archaeologists in the 1920s. The approximately 100 standing stones, up to 1.8 meters tall and arranged around an oval open space, were submerged in the Valdecañas reservoir after the construction of a ...
Source: Science of Aging Knowledge Environment - August 25, 2022 Category: Geriatrics Source Type: research
Animal Care in Radiation Medical Countermeasures Studies
This report provides an overview of the two-day workshop, which includes a series of special topic presentations followed by panel discussions with subject-matter experts from academia, industry partners, and select governmental agencies.PMID:36001810 | DOI:10.1667/RADE-21-00211.1
Source: Radiation Research - August 24, 2022 Category: Physics Authors: Carmen I Rios Brynn A Hollingsworth Andrea L DiCarlo John E Esker Merriline M Satyamitra Toby A Silverman Thomas A Winters Lanyn P Taliaferro Source Type: research
He battled AIDS, COVID-19, and Trump. Now, Anthony Fauci is stepping down
Anthony Fauci, the renowned physician-scientist who has led the $6.3 billion National Institute of Allergy and Infectious Diseases (NIAID) for nearly 4 decades and since early 2020 has been the U.S. government’s voice of scientific reason during the COVID-19 pandemic, will step down from government service in December.
Fauci, 81, had said in
recent interviews
that he planned to retire from the government by the end of President Joe Biden’s administration, but did not give a date until today. He said in a
statement
that although leading NIAID “has been the honor of a lifetime,” he plans to “pursue...
Source: Science of Aging Knowledge Environment - August 22, 2022 Category: Geriatrics Source Type: research
Your Kid ’ s School Needs Better Ventilation to Help Keep COVID-19 in Check
Across the country, K-12 schools are starting their next year of classes in the middle of a COVID-19 surge. As the BA.5 Omicron subvariant drives thousands of reinfections, schools have largely put aside safety measures like mask requirements and physical distancing.
In response, some parents and experts are trying to improve ventilation in schools, since better air quality in buildings can reduce COVID-19’s spread and even improve other health outcomes. But, despite readily available resources—including millions of dollars in funding from the federal government—many schools have not invested in upgrading...
Source: TIME: Health - August 16, 2022 Category: Consumer Health News Authors: Betsy Ladyzhets Tags: Uncategorized biztech2030 COVID-19 healthscienceclimate Source Type: news
UCLA awarded $11.5 million to improve organ, hand and face transplantation
The Dumont –UCLA Transplant Center has received two grants totaling $11.5 million from the federal government for research aimed at making donated organs last longer and helping transplant recipients live longer, healthier lives.The grant projects — one funded by the National Institutes of Health and the other by the Department of Defense — focus specifically on improving outcomes in liver transplantation and in hand and face transplantation.Both initiatives are led by Dr. Jerzy Kupiec-Weglinski, UCLA ’s Paul I. Terasaki Professor of Surgery and vice chair of basic research in the surgery department at theDavid Gef...
Source: UCLA Newsroom: Health Sciences - July 29, 2022 Category: Universities & Medical Training Source Type: news
As pandemics collide, push to end AIDS stumbles
The world’s response to the 5-decade-old HIV/AIDS pandemic is faltering badly in the face of declines in spending and the COVID-19 pandemic, according to annual update from the Joint United Programme on HIV/AIDS (UNAIDS). “The data we are sharing today bring painful but vital news,” said the director of UNAIDS, Winnie Byanyima, at a press conference yesterday to discuss the release of the update. “The response to the AIDS pandemic has been derailed by a global crisis from the colliding pandemics.”
UNAIDS issued the lengthy report, titled
In Danger: UNAIDS Global AIDS Update 2022
, as a run up to the 24...
Source: Science of Aging Knowledge Environment - July 28, 2022 Category: Geriatrics Source Type: research
Why efforts to make better, more universal coronavirus vaccines are struggling
There’s a new call from the White House to develop vaccines that might protect against future SARS-CoV-2 mutants or even unknown coronaviruses. “The vaccines we have are terrific, but we can do better than terrific,” Ashish Jha, White House COVID-19 response coordinator, said at a vaccine summit yesterday that gathered researchers, companies, and government officials. “Ultimately, we need vaccines that can protect us no matter what Mother Nature throws at us.”
But no specific funding request to Congress was revealed at the summit, or any concrete plans, so vaccine developers and the public shouldn’t expect...
Source: Science of Aging Knowledge Environment - July 27, 2022 Category: Geriatrics Source Type: research
Food allergy drug developer Alladapt raises $119M in new funding
A developer of a drug designed to treat a variety of food allergies raised $119 million as it prepares for a potentially pivotal clinical trial.
Alladapt Immunotherapeutics Inc. announced the new funding deal Wednesday. Patient Square Capital's Enavate Sciences unit led the round. Founding investor Gurnet Point Capital and new investors AllerFund, Novartis AG, Red Tree Venture Capital and WestRiver Group participated in the deal.
The Menl o Park company had previously raised a total of $63 million…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 23, 2022 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
